Prothena Corporation plc (NASDAQ: PRTA) kicked off on Tuesday, down -3.82% from the previous trading day, before settling in for the closing price of $10.73. Over the past 52 weeks, PRTA has traded in a range of $4.32-$17.66.
Healthcare Sector giant saw their annual sales slid by -3.15% over the last five years. While this was happening, its average annual earnings per share was recorded -108.22%. With a float of $43.39 million, this company’s outstanding shares have now reached $53.83 million.
Prothena Corporation plc (PRTA) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Prothena Corporation plc is 19.39%, while institutional ownership is 79.70%. The most recent insider transaction that took place on May 02 ’25, was worth 27,744,929. In this transaction 10% Owner of this company sold 3,317,938 shares at a rate of $8.36, taking the stock ownership to the 8,266,342 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 1,984,053 for $7.64, making the entire transaction worth $15,164,712. This insider now owns 5,304,596 shares in total.
Prothena Corporation plc (PRTA) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1.08 earnings per share (EPS), lower than consensus estimate (set at -1.04) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -108.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.74% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Take a look at Prothena Corporation plc’s (PRTA) current performance indicators. Last quarter, stock had a quick ratio of 6.61. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 47.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.21, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach 0.03 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Analysing the last 5-days average volume posted by the [Prothena Corporation plc, PRTA], we can find that recorded value of 0.69 million was lower than the volume posted last year of 0.95 million. As of the previous 9 days, the stock’s Stochastic %D was 39.63%.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 74.86%, which indicates a significant increase from 25.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.58 in the past 14 days, which was higher than the 0.47 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.32, while its 200-day Moving Average is $9.06. Now, the first resistance to watch is $10.67. This is followed by the second major resistance level at $11.02. The third major resistance level sits at $11.24. If the price goes on to break the first support level at $10.10, it is likely to go to the next support level at $9.88. Should the price break the second support level, the third support level stands at $9.53.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
The company with the Market Capitalisation of 555.53 million has total of 53,830K Shares Outstanding. Its annual sales at the moment are 135,160 K in contrast with the sum of -122,310 K annual income. Company’s last quarter sales were recorded 2,420 K and last quarter income was -36,540 K.
